SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-002815
Filing Date
2023-02-15
Accepted
2023-02-14 18:13:18
Documents
12
Period of Report
2023-02-09
Items
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A crbp-20230209.htm   iXBRL 8-K/A 50485
  Complete submission text file 0000950170-23-002815.txt   173046

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230209.xsd EX-101.SCH 2474
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230209_lab.xml EX-101.LAB 13992
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230209_pre.xml EX-101.PRE 11485
6 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230209_htm.xml XML 5343
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37348 | Film No.: 23632482
SIC: 2834 Pharmaceutical Preparations